About Endpoint Outcomes
Endpoint Outcomes is a company based in Boston (United States) founded in 2012 was acquired by Lumanity in June 2022.. Endpoint Outcomes operates in a competitive market with competitors including Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Endpoint Outcomes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endpoint Outcomes
Endpoint Outcomes has secured backing from 1 investor. Prominent investors backing the company include Lumanity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Film production services are provided by Lumanity from London.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endpoint Outcomes
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endpoint Outcomes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endpoint Outcomes Comparisons
Competitors of Endpoint Outcomes
Endpoint Outcomes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| domain | founded_year | HQ Location |
Precision medicine integration is facilitated through analytics and services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Endpoint Outcomes
When was Endpoint Outcomes founded?
Endpoint Outcomes was founded in 2012.
Where is Endpoint Outcomes located?
Endpoint Outcomes is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Endpoint Outcomes?
Christopher Evans is the current CEO of Endpoint Outcomes.
What does Endpoint Outcomes do?
Endpoint Outcomes was founded in 2012 and is headquartered in Boston, United States. Consulting services focused on clinical development, outcome validation, regulatory strategy, and related areas are delivered to clients in the biopharmaceutical sector. Operations emphasize support for drug development processes, ensuring compliance and efficacy in therapeutic advancements. Expertise is applied across various stages of biopharma projects to facilitate informed decision-making.
Who are the top competitors of Endpoint Outcomes?
Endpoint Outcomes's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Who are Endpoint Outcomes's investors?
Endpoint Outcomes has 1 investor. Key investors include Lumanity.